Appropriate utilization of the prognostic 40-gene expression profile (40-GEP) test for cutaneous squamous cell carcinoma (cSCC) demonstrated by clinical reports and physician evaluation of real-world cases

Main Article Content

Aaron Farberg
Jennifer Siegel
Briana Rackely
Alison Fitzgerald
Sarah Kurley
Robert Cook

Keywords

skin cancer

Abstract

N/A

References

1. Karia, et al. JAAD 2012

2. Cañueto et al. JAAD 2019

3. Ruiz et al. JAMA Dermatol 2019

4. Wysong, et al. JAAD 2021

5. Ibrahim, et al. Future Oncology 2021

Most read articles by the same author(s)